Search Within

Myeloma

Formats
  1. Meeting Abstract (557)
  2. Journal Article (368)
  3. Review (37)
  4. Research Letter (21)
  5. Book Section (10)
  6. Guidelines (10)
  7. Correspondence (7)
  8. Editorial (5)
  9. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (1016)
  2. Department of Medicine (1016)
  3. Hematologic Malignancies, Division of (1016)
  4. Hematologic Malignancies Research (669)
  5. Survivorship Research (374)
  6. Sloan Kettering Institute Postdocs (306)

More Groups

People
  1. Alexander Lesokhin (381)
  2. Hani Hassoun (339)
  3. Carl Landgren (336)
  4. Sham Mailankody (297)
  5. Malin Hultcrantz (274)
  6. Heather Landau (249)

More People

Years
  1. 2025 (28)
  2. 2024 (82)
  3. 2023 (115)
  4. 2022 (96)
  5. 2021 (76)
  6. 2020 (95)

More Years

Publications
  1. Blood (317)
  2. Clinical Lymphoma, Myeloma and Leukemia (96)
  3. Journal of Clinical Oncology (86)
  4. Haematologica (41)
  5. Biology of Blood and Marrow Transplantation (29)
  6. Blood Cancer Journal (24)

More Publications

Publishers
  1. American Society of Hematology (340)
  2. Elsevier Inc. (160)
  3. American Society of Clinical Oncology (88)
  4. Nature Publishing Group (87)
  5. Ferrata Storti Foundation (41)
  6. American Association for Cancer Research (34)

More Publishers

Results (1016)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Depth and timing of improvement of response for multiple myeloma patients on lenalidomide maintenance after autologous hematopoietic stem cell transplantation (Auto HCT)
    Meeting Abstract

    Shah, G. L.; Assal, A.; Hsu, M.; Devlin, S. M.; Hassoun, H.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Epidemiology of Waldenström macroglobulinemia
    Book Section

    Steingrímsson, V.; Landgren, O.; Kristinsson, S. Y.
    In Leblond, V.; Treon, S.; Dimoploulos, M. (Eds.) Waldenström's Macroglobulinemia (2017)

    Fulltext@MSK | Save
  • Affordable Care Act, health insurance coverage, and cancer outcomes
    Journal Article

    Mailankody, S.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • The checkpoint inhibitor TTI-621 (SIRPαFc) stimulates innate and adaptive immune responses in patients with hematologic and solid tumor malignancies
    Meeting Abstract

    Johnson, L.; Ansell, S.; Chen, R.; Flinn, I.; Maris, M.; O'Connor, O.; Lesokhin, A.; Thompson, J.; Akilov, O.; Querfeld, C.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Extra-medullary plasmacytoma masquerading as a cecal polyp
    Meeting Abstract

    Simoes, P. K.; Park, D. C.; Hani, H.; Mendelsohn, R. B.
    American Journal of Gastroenterology (2017)

    Fulltext@MSK | Save
  • Hormone replacement therapy and risk of multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS) and MGUS progression in the UK Clinical Practice Research Datalink
    Meeting Abstract

    Bradley, M. C.; McShane, C.; Hughes, C. M.; Landgren, O.; Murray, L.; Anderson, L. A.
    Pharmacoepidemiology and Drug Safety (2017)

    Fulltext@MSK | Save
  • Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM
    Meeting Abstract

    Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Peripheral neuropathy is an under-recognized feature of monoclonal gammopathy of undetermined significance: A population-based study of 18,668 MGUS patients and their 97,641 matched controls
    Meeting Abstract

    Rögnvaldsson, S.; Steingrímsson, V.; Turesson, I.; Björkholm, M.; Landgren, O.; Kristinsson, S. Y.
    Blood (2017)

    Fulltext@MSK | Save
  • Melflufen therapy for relapsed refractory multiple myeloma (RRMM) patients refractory to daratumumab and/or pomalidomide: A report on early efficacy
    Meeting Abstract

    Mateos, M. V.; Bladé, J.; Larocca, A.; Oriol, A.; Rodriguez, P.; Alegre, A.; Cavo, M.; Moreb, J. S.; Paner, A.; Gabrail, N.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Costs and in-hospital mortality rates in autologous stem cell transplant for multiple myeloma: An analysis of the Nationwide Inpatient Sample (NIS) Database
    Meeting Abstract

    Liu, Y.; Han, H.; Wei, X.; Wang, Q.; He, J.; Shah, G. L.; Giralt, S. A.; Landgren, O.; Lesokhin, A.
    Blood (2017)

    Fulltext@MSK | Save